Vorapaxar is a thrombin receptor antagonist derived from the natural product himbacine. It is used as an active pharmaceutical ingredient in the manufacturing of medicines targeting the protease-activated receptor-1.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 618385-01-6
Vorapaxar sulfate
pharmaceutical raw material
Dihydroergotamine mesylate
pharmaceutical raw material
Dimepranol acedoben
pharmaceutical raw material
Adrenalone hydrochloride
pharmaceutical raw material
Dopamine hydrochloride
pharmaceutical raw material
ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate
ZBGXUVOIWDMMJE-QHNZEKIYSA-N
CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C